The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II
Authors:
Open Access
- 28 April 2011
- journal article
- review article
- Published by Wiley in International Journal of Molecular Imaging
- Vol. 2011, 1-11
Abstract
The clinical management of adults with low-grade gliomas (LGGs) remains a challenge. There is no curative treatment, and management of individual patients is a matter of deciding optimal timing as well as right treatment modality. In addition to conventional imaging techniques, positron emission tomography (PET) with amino acid tracers can facilitate diagnostic and therapeutic procedures. In this paper, the clinical applications of PET with amino acid tracers 11C-methyl-L-methionine (MET) and 18F-fluoro-ethyl-L-tyrosine (FET) for patients with LGG are summarized. We also discuss the value of PET for the long-term followup of this patient group. Monitoring metabolic activity by PET in individual patients during course of disease will provide insight in the biological behavior and evolution of these tumors. As such, spatial changes in tumor activity over time, including shifts of hot-spot regions within the tumor, may reflect intratumoral heterogeneity and correlate to clinical parameters.Keywords
Funding Information
- Uppsala University
- Lions Cancer Foundation
This publication has 87 references indexed in Scilit:
- Advanced MRI and PET imaging for assessment of treatment response in patients with gliomasThe Lancet Neurology, 2010
- Management of Low-Grade GliomaCurrent Neurology and Neuroscience Reports, 2010
- 11C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: A stereotactic image-histology comparisonNeuroImage, 2010
- Comparison of 18F-FET and 18F-FDG PET in brain tumorsNuclear Medicine and Biology, 2009
- [11C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumorsJournal of Neuro-Oncology, 2009
- Prognostic significance of imaging contrast enhancement for WHO grade II gliomasNeuro-Oncology, 2009
- [(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade gliomaRadiation Oncology, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC trial 22844)European Journal of Cancer, 1998
- Long-term positron emission tomography evaluation of slowly progressive gliomasEuropean Journal of Cancer, 1996